Optimising treatment of schizophrenia: the role of adjunctive fluvoxamine Siobhan GeeOliver Howes Editorial 16 January 2016 Pages: 739 - 740
The clinical potentials of adjunctive fluvoxamine to clozapine treatment: a systematic review Christoffer PolcwiartekJimmi Nielsen Review 02 December 2015 Pages: 741 - 750
Blunted striatal response to monetary reward anticipation during smoking abstinence predicts lapse during a contingency-managed quit attempt Maggie M. SweitzerCharles F. GeierEric C. Donny Original Investigation 11 December 2015 Pages: 751 - 760
Effects of the nicotinic agonist varenicline on the performance of tasks of cognition in aged and middle-aged rhesus and pigtail monkeys Alvin V. Terry JrMarc PlagenhoefPatrick M. Callahan Original Investigation 27 November 2015 Pages: 761 - 771
Enhanced cocaine-induced locomotor sensitization and intrinsic excitability of NAc medium spiny neurons in adult but not in adolescent rats susceptible to diet-induced obesity Max F. OginskyJoel D. MaustCarrie R. Ferrario Original Investigation 27 November 2015 Pages: 773 - 784
Lithium ions attenuate serum-deprivation-induced apoptosis in PC12 cells through regulation of the Akt/FoxO1 signaling pathways Zhiwen ZengHaitao WangWenhua Zheng Original Investigation 02 December 2015 Pages: 785 - 794
Brain Angiotensin II AT1 receptors are involved in the acute and long-term amphetamine-induced neurocognitive alterations Natalia Andrea MarcheseEmilce Artur de laVillarmoisClaudia Bregonzio Original Investigation 28 November 2015 Pages: 795 - 807
Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use Christian NúñezSusana OchoaJudith Usall Original Investigation 01 December 2015 Pages: 809 - 821
Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities Joaquim SolerMatilde ElicesJordi Riba Original Investigation 27 November 2015 Pages: 823 - 829
Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens Kequan FuHuiyang LinAtsumi Nitta Original Investigation 01 December 2015 Pages: 831 - 840
Reciprocal activation/inactivation of ERK in the amygdala and frontal cortex is correlated with the degree of novelty of an open-field environment Frederico Velasco SanguedoCaio Vitor Bueno DiasMarinete Pinheiro Carrera Original Investigation 19 December 2015 Pages: 841 - 850
The effects of cognitive reappraisal following retrieval-procedures designed to destabilize alcohol memories in high-risk drinkers Tiffany HonRavi K. DasSunjeev K. Kamboj Original Investigation Open access 14 December 2015 Pages: 851 - 861
Acute effects of BZP, TFMPP and the combination of BZP and TFMPP in comparison to dexamphetamine on an auditory oddball task using electroencephalography: a single-dose study HeeSeung LeeGrace Y. WangBruce R. Russell Original Investigation 03 December 2015 Pages: 863 - 871
Interactions between imidazoline I2 receptor ligands and acetaminophen in adult male rats: antinociception and schedule-controlled responding Justin N. SiemianJiuzhou LiJun-Xu Li Original Investigation 28 November 2015 Pages: 873 - 882
Altered cognitive response to serotonin challenge as a candidate endophenotype for obsessive-compulsive disorder Christine LochnerSamuel R. ChamberlainDan J. Stein Original Investigation 09 December 2015 Pages: 883 - 891
Effects of D2 or combined D1/D2 receptor antagonism on the methamphetamine-induced one-trial and multi-trial behavioral sensitization of preweanling rats Alena Mohd-YusofAna VelizSanders A. McDougall Original Investigation 09 December 2015 Pages: 893 - 903
Minocycline protects against lipopolysaccharide-induced cognitive impairment in mice Yue HouGuanbo XieBing Wang Original Investigation 08 December 2015 Pages: 905 - 916
The ad-libitum alcohol ‘taste test’: secondary analyses of potential confounds and construct validity Andrew JonesEmily ButtonMatt Field Original Investigation Open access 18 December 2015 Pages: 917 - 924
Attenuation in rats of impairments of memory by scopolamine, a muscarinic receptor antagonist, by mecamylamine, a nicotinic receptor antagonist L. A. NewmanP. E. Gold Original Investigation 10 December 2015 Pages: 925 - 932
